Wangdong Deng

7PUBLICATIONS
3CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Particle and high energy physics not elsewhere classifiedNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 26, 2026
When heterogeneity dominates: interpreting TBS-UAS benefits in RIRS with prediction intervals.

Zuomin Wang, Qinwei Liu, Wangdong Deng

|Jan 26, 2026
TMIGD2 in Bladder Cancer: A Bioinformatics and Experimental Approach to Understanding its Prognostic and Therapeutic Potential.

Yiwen Chen, Meiting Lao, Mingfeng Shen

|Jan 26, 2026
Exploring ZPLD1 as a Prognostic Indicator and Therapeutic Target in Bladder Cancer.

Yiwen Chen, Hanliang Zhu, Meiting Lao

|Jan 15, 2026
When coverage is not enough: the case for strengthening uro-oncology Worldwide.

Zuomin Wang, Qinwei Liu, Wangdong Deng

|Jan 08, 2026
Exosome diagnostics beyond the hype: why study design still matters.

Zuomin Wang, Qinwei Liu, Wangdong Deng

|Nov 24, 2025
From Creatinine Cut-Offs to Bedside Precision: A Road-Map for Safer Terlipressin in Early Hepatorenal Syndrome.

Zuomin Wang, Qinwei Liu, Wangdong Deng

Pageof 2

Frequent Collaborators

3 joint publications

Dongbing Li

3 joint publications

Yiwen Chen

1 joint publications

Zuomin Wang